HOME >> MEDICINE >> NEWS
'Moral clarity' espoused in debate over health-care reform

When the Clinton health care reform initiative died in 1994, the problems it promised to address didn't disappear with it; they grew worse.

More than a decade later, the United States' population has reached 300 million, a large percentage lacking adequate--or any--health care. Figures vary, but approximately 45 million Americans have no health insurance at all and another 20 to 30 million are underinsured, while many more are at risk of losing what little they have.

A new collection of essays, Health Care Reform: Ethics and Politics (University of Rochester Press), questions the ethics of having so many citizens without basic health care--the middle aged who have lost their jobs and benefits, children of uninsured parents--and proposes ways of moving beyond the standard ideological roadblocks.

The anthology, edited by Timothy Engstrm and Wade Robison, professors of philosophy at Rochester Institute of Technology, call for a renewed national dialogue committed to revamping the U.S. health care model guided by moral principles in balance with political and economical realities.

Health Care Reform grew from a conference held at RIT in 1995 and shows how little has improved since the failed Clinton initiative. Essayists include Howard Brody, a former consultant with the Clinton administration's Health Care Reform Task Force; Norman Daniels, from Harvard School of Public Health; and Uwe Reinhardt, who sat on the National Advisory Council for Health Care Policy, among others.

"The message throughout the book is that moral clarity comes first and that clear policies can and must follow," says Robison.

The escalating costs of health care force companies to cut benefits and transfer costs to employees to remain profitable or, paradoxically, to move abroad to countries with a national health care system--all decisions that compromise individuals' and the nation's economic health.

"What is ironic about o
'"/>

Contact: Susan Gawlowicz
smguns@rit.edu
585-475-5061
Rochester Institute of Technology
16-Nov-2006


Page: 1 2

Related medicine news :

1. Experts debate role of stenting, bypass surgery in left main coronary artery disease
2. Doctors must debate hospital closures
3. Time for a debate in the USA on health care
4. AIDS debate launches Lancet podcast
5. Beta-blockers for high blood pressure ongoing debate
6. Time is right for vets and doctors to debate food policy
7. Pain that brings us to our knees a great debate on a bone of contention
8. The Lancet calls for open debate on illegal drug use
9. PSA screening for prostate cancer to be debated at annual meeting forum
10. RAND, Health Dialog form alliance to create tools to evaluate health-care quality and efficiency
11. Law professor finds home health-care workers have few legal protections

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moral clarity espoused debate over health care reform

(Date:10/22/2014)... only 24 hours in a day, that doesn’t seem to be ... their busy schedules for exercise and fitness. Fortunately, one does not ... shape. Here are five ways you can reach your fitness and ... Commute , Consider riding a bike or taking the bus or ... If you must use your car to get to work, start ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts ... facts, figures and forecasts on the global medical markets. ... categories the Worldwide Medical Market Forecasts to 2019 ... on the worldwide medical market to reveal key insights ... data for 2010-2019, covering each country market individually, allowing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: